Companies: 10,795·Total market cap: $144.5T
Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc.

LFCRNASDAQHealthcare● Active
$5.57
$-0.06(-1.07%)
Market Cap$208927397
P/E Ratio
52W High$8.98
52W Low$3.63
Overview

Lifecore Biomedical, Inc. (LFCR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LFCR · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.03lfcr eps ttm · lfcr earnings per shareEarnings history
PE Ratio (TTM)lfcr pe ratio ttm · lfcr price to earningsPE Ratio deep dive
Revenue (TTM)$135.2Mlfcr revenue ttm · lfcr annual revenueFull revenue history
Dividend YieldNo Dividenddoes lfcr pay dividends · lfcr dividend yieldDividend history
Shares Outstanding34.8Mlfcr shares outstanding · lfcr floatShares outstanding history
Next EarningsJul 31, 2026Est.lfcr earnings date · lfcr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$128.9M▲ +0.47% YoY
202320242025
lifecore biomedical, inc. revenue · lfcr revenue 2025
FY 2025Net Income-$38.7M▼ 422.29% YoY
202320242025
lifecore biomedical, inc. net income · lfcr profit 2025
FY 2025EPS$-1.27▼ 425.64% YoY
202320242025
lfcr eps · lifecore biomedical, inc. earnings per share 2025
TTM:Revenue: $135.2MNet Income: -$34.1MEPS: $-1.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis lfcr a buy · lfcr analyst rating
Strong Buy
0
Buy
5
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$5.57Current
$6.00Avg Target7.72% upside
$6.00High
lfcr price target · lfcr 12 month forecast

Total: 7 · Buy rate: 71.4%

The LFCR analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +7.72% upside from the current price of $5.57.

Stock Performance

Full History
1D-1.42%
1W+1.65%
1M+15.87%
3M-20.26%
YTD-32.15%
1Y-18.14%
5Y-56.33%

About Lifecore Biomedical, Inc.

CEOPaul Josephs
IPO DateFeb 15, 1996
Employees524
CountryUS

Lifecore Biomedical, Inc. together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through L…

what is lifecore biomedical, inc. · lfcr stock overview · lifecore biomedical, inc. company profile · who is lifecore biomedical, inc. ceo · lfcr NASDAQ · lifecore biomedical, inc. headquarters · lifecore biomedical, inc. business segments

About Stock Overview & Key Data

Lifecore Biomedical, Inc. (LFCR) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 15, 1996. As of the latest trading session, LFCR stock price is $5.57, with a market capitalization of $208.2M. The stock has returned -18.14% over the past 12 months and -32.15% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Lifecore Biomedical, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Lifecore Biomedical, Inc. reported revenue of $128.9M and net income of -$38.7M. For detailed data — including Lifecore Biomedical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lifecore Biomedical, Inc. (LFCR) stock price is $5.57. The stock is traded on NASDAQ under the ticker symbol LFCR. The 52-week range is $3.63 – $8.98.

LFCR stock priceLFCR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice